Key therapeutic categories

  • Dermatology
  • Respiratory
  • Anti-infective
  • Cardio-metabolic

We established our presence in Asia region in 1989 with the launch of our Candid product range in Sri Lanka and today, we rank among the top 21 companies in the country. Glenmark is ranked no. 1 in dermatology therapy and is one of the leading players in respiratory medicine in Sri Lanka.

Our progress led to establishing ourselves further in the region and currently we have successful operations across 14 markets in Asia with a key focus on Philippines, Malaysia, Vietnam, Myanmar and Sri Lanka. We also rank among the top generic companies in Myanmar and Malaysia and enjoy a leadership position in the areas of dermatology, cough management and gastrointestinal segments.

With over 60 products being successfully marketed in this region, our strategy is to focus on power brands that contribute substantially to the overall sales.




Glenmark Pharmaceuticals Singapore Pte. Ltd. Suntec Tower Three Level 42, 8 Temasek Boulevard, Singapore 038988


Glenmark Pharmaceuticals Ltd. Room 3, 4th Floor, Ocean Park Building, No. 1 Dao Duy Anh, Phuong Mai ward, Dong Da Str., Ha Noi, Viet Nam


Glenmark Pharmaceuticals Ltd. No(2D/7A), Myint Zu 2nd Street, Parami Road, Yankin Township, Yangon, Myanmar


Glenmark Pharmaceuticals 9th Floor 11th Corporate Center 11th Avenue corner Triangle, Drive North Bonifacio, Bonifacio Global City, Taguig City


Glenmark Pharmaceuticals C-3-5, Block C, 3rd floor, Megan Avenue 1, 189, Jalan Tun Razak, Kuala Lumpur 50400 Malaysia

Markets The geographies we cater to:

  • Malaysia
  • Myanmar
  • Philippines
  • Sri Lanka
  • Vietnam
  • Cambodia
  • Laos